Imvax
With over twenty-five years of experience in the life sciences industry, Sean Hemingway has progressed through roles in project management, product operations, strategy, and operations. He has held various executive positions, beginning with positions in engineering, tech transfer, project and program management and moving into executive roles in corporate operations, product, and strategy management. Sean’s professional experience includes roles at Pfizer, Genzyme, and Baxalta, and he most recently was the Global Head of the BioLife Plasma Services business unit at Takeda. In addition, Sean has worked in domestic and international positions and has played key roles in several corporate integrations.
He holds a B.S. in Chemical Engineering from the University of Rhode Island and an M.S. in Engineering Management from Tufts University.
This person is not in any offices
Imvax
1 followers
Imvax is a clinical-stage biotechnology company with a unique immunotherapy approach to solid tumors.